UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047727
Receipt number R000054380
Scientific Title Prospective study of patient / patient's caregiver and physician preferences for treatment of hemophilia
Date of disclosure of the study information 2022/05/13
Last modified on 2022/06/07 17:23:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study of patient / patient's caregiver and physician preferences for treatment of hemophilia

Acronym

Prospective study of preferences for treatment of hemophilia

Scientific Title

Prospective study of patient / patient's caregiver and physician preferences for treatment of hemophilia

Scientific Title:Acronym

Prospective Study of Preferences for Treatment of Hemophilia

Region

Japan


Condition

Condition

Hemophilia

Classification by specialty

Medicine in general Hematology and clinical oncology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine and quantify preferences of patient /patients caregiver and physician for regular treatment of hemophilia

Basic objectives2

Others

Basic objectives -Others

Examine the similarities and differences in perceptions of treatment between patient/patient's caregiver and physician

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Examine the similarities and differences in perceptions of treatment between patient/patient's caregiver and physician (DCE)

Key secondary outcomes

Examine the similarities and differences in perceptions of treatment between patient/patient's caregiver and physician.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients
1) Age 18 years or older
2) Current without inhibitor
3) Has 6 months or more experience with self-injection of prophylactic treatment with a coagulation factor preparation
4) Willing and able to provide consent, indicating that they understand the purpose and procedures required for the study and are willing to participate in the study

Patient caregivers
1) Caregiver of hemophilia under 18 years
2) Caregiver of patient currently without inhibitor
3) Has 6 months or more experience with injection of prophylactic treatment with a coagulation factor preparation
4) Willing and able to provide consent, indicating that they understand the purpose and procedures required for the study and are willing to participate in the study

Physicians
1) Targeted specialists (general internists medicine, hematologists, pediatrics)
2) Have treated at least one patient with hemophilia with drugs within the past year
3) Willing and able to provide consent, indicating that they understand the purpose and procedures required for the study and are willing to participate in the study

Key exclusion criteria

Those that do not meet the inclusion criteria

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Ayumi
Middle name
Last name Deguchi

Organization

Novo Nordisk Pharma Ltd

Division name

Medical Affairs Department

Zip code

100-0005

Address

2-1-1 Marunouchi, Chiyoda-ku, Tokyo, Japan

TEL

+81362661000

Email

ayud@novonordisk.com


Public contact

Name of contact person

1st name Michael
Middle name
Last name LoPresti

Organization

INTAGE Healthcare Inc.

Division name

Health Economics & Outcomes Research Division

Zip code

101-0062

Address

13F Ochanomizu SolaCity, 4-6 Kanda-Surugadai, Chiyoda-ku, Tokyo

TEL

+815036401444

Homepage URL

https://www.intage-healthcare.co.jp/

Email

m.lopresti@intage.com


Sponsor or person

Institute

INTAGE Healthcare, Inc.

Institute

Department

Personal name



Funding Source

Organization

Novo Nordisk Pharma Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Keiaikai Saga Memorial Hospital

Address

1240-1 Takagise-cho, Saga City, Saga Prefecture

Tel

0952-31-7771

Email

sagakinen8490917@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 02 Month 15 Day

Date of IRB

2022 Year 04 Month 13 Day

Anticipated trial start date

2022 Year 05 Month 20 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Enrolling by invitation


Management information

Registered date

2022 Year 05 Month 12 Day

Last modified on

2022 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054380


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name